POS0242 THE EFFECT OF ANTIMALARIALS ON THE OVERALL SAFETY AND PERSISTENCE OF TREATMENT WITH BIOLOGIC AGENTS OR JAK INHIBITORS IN RHEUMATOID ARTHRITIS

Autor: M. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira DE Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, H. De Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. Kakehasi, P. Louzada, A. L. S. Hayata, F. Pina, M. Alves Ferreira, L. Balarini, I. G. Silveira, S. Kowalski, D. Titton, R. Mendonça Da Silva Chakr, A. Ranzolin, I. Laurindo, R. Xavier

Publikováno v: Annals of the Rheumatic Diseases. 81:360.2-361

BackgroundAntimalarials (AM) are frequently part of the initial scheme of conventional synthetic DMARDs in the treatment of rheumatoid arthritis (RA), and have been associated with lower incidence of diabetes and better lipid profile in these patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ceb18110f322c04db0a32d4ddf73805
https://doi.org/10.1136/annrheumdis-2022-eular.4120

AB1173 INCIDENT CASES OF COVID-19 AND VACCINATION ADHERENCE IN A MULTICENTRIC COHORT OF INFLAMMATORY ARTHRITIS IN BRAZIL

Autor: S. M M de Souza, A. C. Medeiros-Ribeiro, M. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, R. Botelho, C. Brenol, H. M. Da Silveira DE Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, H. De Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. Kakehasi, P. Louzada, A. L. S. Hayata, F. Pina, M. Alves Ferreira, L. Balarini, I. G. Silveira, S. Kowalski, D. Titton, R. Mendonça Da Silva Chakr, A. Ranzolin, I. Laurindo, R. Xavier

Publikováno v: Annals of the Rheumatic Diseases. 81:1701.3-1702

BackgroundThe SARS-CoV-2 virus has caused a worldwide health crisis. Patients with inflammatory arthritis are at higher risk of hospitalization and death by COVID-19 due to comorbidities or immunosuppressive treatments. Vaccination is one the most im

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d9870f5ed931b4376d32fb010ace9fcd
https://doi.org/10.1136/annrheumdis-2022-eular.4722

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia.

Autor: Chakr RM; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil. Electronic address: rafaelchakr@gmail.com., Brenol C; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil., Ranzolin A; Universidade Federal de Pernambuco (UFPE), Recife, PE, Brasil., Bernardes A; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil., Dalosto AP; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil., Ferrari G; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil., Scalco S; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil., Olszewski V; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil., Kohem C; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil., Monticielo O; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil., Brenol JC; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil., Xavier RM; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil.

Publikováno v: Revista brasileira de reumatologia [Rev Bras Reumatol] 2016 Dec 18. Date of Electronic Publication: 2016 Dec 18.